Overview Financials News + Filings Key Docs Ownership Insiders
|
|
Bellevue Life Sciences Acquisition Corp.
|
|
| Credit Analysis |
|
|
|
|
Annual | Quarterly |
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 |
| | Source | Source |
| Short-term debt | 1.2 | 0.4 |
| Total debt | 1.2 | 0.4 |
| Net debt | 1.1 | 0.4 |
| |
| Debt to EBITDA | 33.9 | 120.9 |
| Net debt to EBITDA | 30.4 | 119.5 |
| |
|